Drug Type: Chelating Agent, Antidote, Antirheumatic

Sodium calcium edetate (EDTA)

Sodium calcium edetate (EDTA), also known as edetate calcium disodium, is an intravenous heavy metal chelating agent primarily used in the treatment of severe lead poisoning. Use of this medication is often referred to as EDTA therapy, and is usually administered concurrently with dimercaprol (BAL) continuously for a maximum of 5 days.
  • 10-40 mg/kg IV or IM, twice a day for 5-1 days with concurrent fluid therapy.
  • Kidney damage
  • Depletes zinc and copper levels, greatly increasing risk of zinc deficiency.